JPRN-UMIN000049310已完成Unknown
Effects of Lemborexant on insomnia in patients with schizophrenia : A randomized controlled study - Effects of Lemborexant on insomnia in patients with schizophrenia : A randomized controlled study
Department of Psychiatry, Kurita Hospital, 695 Kurita Nagano-City Nagano, Japan, 380-09210 个研究点目标入组 0 人开始时间: 2022年11月1日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Coexisting with mood disorder, anxiety disorder, drug addiction, or personality disorder. 2.Suffering from serious physical diseases such as cerebrovascular disease, heart disease, renal dysfunction, and neurological disease. 3.Coexisting with other sleep disorders such as hypersomnia, sleep-related breathing disorders, circadian rhythm sleep disorders, parasomnia, and sleep-related movement disorders. 4.Actigraphy cannot be performed safely.
研究者
相似试验
已完成
不适用
Efficacy and safety of lemborexant in insomnia patients with nocturia.JPRN-UMIN000044383Kyowakai Medical Corporation Kyoritsu Hospital30
尚未招募
Unknown
se of Lemborexant for Insomnia in Our Clinic: A Retrospective StudyInsomniaJPRN-UMIN000054075Wellness General Clinic1,000
终止
2 期
The Effects of Lemborexant on the Ability to Sleep During DaytimeShift-Work Sleep DisorderNCT06231641Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal5
招募中
4 期
emborexant for insomnia in patients with psychiatric disorder: A 1-week, open-label studyInsomniaJPRN-UMIN000041321Fujita Health University School of Medicine100
已完成
不适用
Evaluation of ramelteon for insomnia in patients with obstructive sleep apnea syndrome.Insomnia in patients with obstructive sleep apnea syndrome.JPRN-UMIN000025514Second Department of Internal Medicine, Nara Medical University30